Life Sciences Regulations Telemedicine 
Health Populi
AUGUST 12, 2021
For this annual report, Ordr analyzed security risks across over 500 deployments in healthcare, life sciences, retail, and manufacturing sectors for the 12 months June 2020 through June 2021. What’s unclear is how public policy and regulation can/will meet this moment. How to protect vulnerable groups of people?
HIT Consultant
MARCH 31, 2024
With an eye toward the future, healthcare and life sciences (HLS) organizations integrating CPQ are set to fundamentally alter traditional care delivery and management models. Any organization aiming to enhance operational efficiency and bolster patient care now sees a finely-tuned CPQ system as table stakes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
MARCH 9, 2023
Cristina Varner, Newfront, SVP National Life Science & Healthcare Practice Gone are the days when healthcare information was only available to us at the doctor’s office or through the office’s online portals, and that’s in part due to the rapidly growing popularity of wearable technology devices.
Healthcare It News
SEPTEMBER 16, 2021
We understand the importance and significant opportunity involved in ensuring that African data is represented in Life Sciences research in the near to long term. The added pressure of the COVID-19 pandemic on providers has made any solution that saves time and promotes telemedicine essential.
HIT Consultant
FEBRUARY 19, 2023
Regulators are now looking beyond clinical indications such as tumor size and delayed disease progression. These insights help regulators, payers and providers understand treatments through the eyes of the patient, including how symptoms and adverse events impact study medication adherence and quality of life across patient populations.
HIT Consultant
MAY 31, 2023
Conversely, competition within the healthcare market benefits patients because it helps regulate and contain prices as pharmaceutical and marketing companies compete for sales. It is important to exercise caution with the concentration of the telemedicine as it could lead to additional care issues.
Health Populi
JUNE 24, 2021
While telehealth and virtual care stood up quickly in 2020, questions remain about how it will/can persist in terms of funding, regulation, and business models. We also expect innovation to come out of pharma and biotech labs, and who will pay for new-new therapies?
Expert insights. Personalized for you.
174 
Let's personalize your content